Long-term Assessment of Rhône RéPPOP Care for Overweight and Obese Children.

Overview

Childhood obesity is a major public health issue since it is a risk factor of adulthood obesity, cardiovascular disease, psychological disorders, and other chronic conditions. RéPPOP is a two year personalized pathway for multidisciplinary care for overweight and obese children, close to patients' homes. Short and medium-term assessments of Rhône RéPPOP care for overweight and obese children show encouraging results. Long-term assessment is needed to confirm these results. The present study aims to assess the long-term efficiency of Rhône RéPPOP care for overweight and obese children by comparing BMI Z-scores at the start and the end of RéPPOP care to the current BMI. This data will be collected through a telephonic questionnaire by the scientific manager. The study's secondary objectives are to evaluate patients and their families' lifestyle changes and to improve RéPPOP practices.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 7, 2021

Interventions

  • Other: Collected data from Rhône RéPPOP database
    • BMI Z-scores at the start and the end of RéPPOP care programs.
  • Other: telephonic questionnaire
    • Collected data though the telephonic questionnaire : current declared BMI Z-score.

Arms, Groups and Cohorts

  • Overweight and obese children
    • Overweight and obese children included in RéPPOP care programs between 2007 and 2010.

Clinical Trial Outcome Measures

Primary Measures

  • Comparison of BMI Z-scores at the start and the end of RéPPOP care programs to the current BMI Z score.
    • Time Frame: Day 0

Participating in This Clinical Trial

Inclusion Criteria

  • All overweight and obese children included in RéPPOP care programs from 01/01/07 to 31/12/10 Exclusion Criteria:

  • Refusal to respond to the telephonic questionnaire – Subjects who withdraw their consent to participate in the study – Subjects aged under 12 years

Gender Eligibility: All

Minimum Age: 13 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospices Civils de Lyon
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Marc NICOLINO, MD, Principal Investigator, Hospices Civils de Lyon, Endocrino-pediatric service, HFME

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.